@Tagworkspharma

Delivering a new class of ADCs and targeted radionuclide therapies for solid tumors with our proprietary Click-to-Release treatment platform

 Nijmegen, The Netherlands
tagworkspharma.com
Joined February 2013
  • Tweets49
  • Following230
  • Followers233
13Media
We are excited to announce the initiation of our Phase 0/1 clinical trial, sponsored by @radboudumc , evaluating TGW211 in patients with #HER2positive #tumors. Learn more: bit.ly/4hcgGk8
1
2
103
On #WorldCancerResearchDay, we’re reminded that bold scientific innovation is essential. Hear from Marc Robillard, PhD, Tagworks’ co-founder and CSO, about how we’re advancing pioneering in vivo click chemistry into a new standard of care for patients with #solidtumors.
2
89
We’re excited to announce that the third dose level has been initiated in our ongoing Phase 1 clinical trial evaluating our lead #ADC program TGW101 in patients with advanced #solidtumors. Learn more: bit.ly/4859Eej
64
We’re innovating for patients with #solidtumors so they can have safer, more effective therapies. Developed with our pioneering Click-to-Release approach, our lead #oncology #ADC program called TGW101 is now recruiting for a #clinicaltrial. Learn more: bit.ly/44ykreP
5
158
We’re proud to be featured in a #NatureBiotechnology profile on #radiopharmaceuticals! Our Click-to-Release treatment platform shows potential to remove dose-limiting toxicities to more safely and effectively treat #solidtumors. Read here: bit.ly/4mFOoB1
2
12
558
At #AACR2025, we presented preclinical data on the potential of our Click-to-Release treatment platform to enable safe, tolerable, and potent delivery of therapeutic candidates for #solidtumors. View the posters: bit.ly/4cM7yjT #ADCs #oncology
1
3
106
We’re excited to welcome Keith Orford, MD, PhD, as our new CMO! His leadership in #oncology research and clinical drug development will be invaluable as we transition to the clinic. Learn more: bit.ly/4jlSuw3
2
89
We’re thrilled to announce the initiation of our Phase 1 clinical trial evaluating TGW101, an #ADC developed with our Click-to-Release treatment platform, in patients with advanced #solidtumors. Learn more: bit.ly/4jrAErw
1
12
376
We look forward to attending #AACR2025! We will share preclinical data that demonstrate the potential of our pioneering Click-to-Release platform to improve the standard of care for patients with #solidtumor #cancers. Learn more: bit.ly/41HXGDZ #ADCs #oncology
1
136
We're excited to announce Ken Mills has been appointed our new CEO and that Marc Robillard will continue as CSO & Board member. We look forward to working to bring our Click-to-Release platform and lead ADC program for solid tumors into the clinic in 2025. prnewswire.com/news-releases…
1
1
6
393
Proud to have won the second place for this years LSX Lifestars Awards - Series A of the Year. Great recognition for @Tagworkspharma and our fantastic group of investors ! Congrats to Complement Tx and Adcendo and thanks to @lifestarsawards for this great night out !
8
410
A concise synthetic approach to highly reactive click-to-release trans-cyclooctene linkers (Robillard et al. @Tagworkspharma) chemistry-europe.onlinelibra…

A Concise Synthetic Approach to Highly Reactive Click‐to‐Release Trans‐Cyclooctene Linkers **

Intramolecular iodolactonization was employed for the efficient and stereoselective conversion of an sTCO click-conjugation precursor to a highly reactive and stable click-cleavable sTCO antibody...

chemistry-europe.onlinelibrary.wiley.com
5
1
29
5,347
Tagworks Pharmaceuticals retweeted
Jordi Xiol@jordixiol6 Jul 2023
‘Clicked’ drugs: researchers prove the remarkable chemistry in humans Featuring @Tagworkspharma #portfolio nature.com/articles/s41587-0…

‘Clicked’ drugs: researchers prove the remarkable chemistry in humans

Nature Biotechnology - Bioorthogonal click chemistry is being used in patients to help target cancer medicines and diagnostic imaging agents

nature.com
5
12
1,918
Tagworks Pharmaceuticals retweeted
C2W@Chem2W22 Jun 2023
Het Nederlandse @Tagworkspharma heeft een grote investeringsronde met succes afgesloten. De financiële impuls biedt het bedrijf de middelen om klinische studies met de belangrijkste kandidaat-ADC in gang te zetten: sciencelink.net/nieuws/tagwo…
1
2
7
588
We’re excited to announce that we’ve raised $65 Million in Series A financing to advance a pipeline of Click-to-Release Therapeutics ! tagworkspharma.com/tagworks-…
6
3
2
48
6,596
Tagworks Pharmaceuticals retweeted
B&BSymposium@BBSymposium128 Apr 2023
Meet our speakers: Marc Robillard. Cleavable Radioimmunoimaging to increase tumour-to-blood ratio. biorxiv.org/content/10.1101/… @dynafluors @boomchemistry @Tagworkspharma @RSC_CBBG
3
6
607
We have an exciting opportunity for a synthetic chemist to contribute to the development of new cancer therapies based on Tagworks’ Click-to-Release platform tagworkspharma.com/company/c…
6
7
Check out this overview of bioorthogonal chemistry. Thanks to Joe Fox and Sam Scinto @FoxGroupUD for leading the charge !
Nature Reviews Methods Primers@MethodsPrimers15 Apr 2021
Looking for ways to conduct bioorthogonal chemistry? Have a look at our in-depth overview of this useful toolbox in this week's Primer @FoxGroupUD @WankyuL @klanglab @jenn_prescher @seansn2015 @UCIChemistry @UCIrvine @Tagworkspharma go.nature.com/3uSj4mR

Bioorthogonal chemistry

Nature Reviews Methods Primers - The underlying mechanisms and optimal conditions that drive biorthogonal reactions and the utility of these for applications in medicinal chemistry and protein...

nature.com
8
We have an exciting opportunity for a synthetic chemist to contribute to development of new cancer therapies based on Tagworks’ Click-to-Release platform tagworkspharma.com/company/c…
22
2
34
Happy to report that our paper on a new and highly reactive Click-to-Release reaction is now out in @J_A_C_S. Great collaboration between @Tagworkspharma and SyMO-Chem, Syncom, @TUeindhoven, Avipep and Levena. pubs.acs.org/doi/abs/10.1021…
1
15
1
76
Load more